Dr. Christine Edwards -- Pharmaceutical Payment Report

This page provides a comprehensive transparency report for Dr. Christine Edwards, a Dermatology physician based in Los Angeles, CA. All payment data is sourced from the CMS Open Payments (Sunshine Act) database. Dr. Christine Edwards has received $16,564.42 in total pharmaceutical industry payments across 1 transactions from 1 pharmaceutical companies.

Physician Profile

The following profile information is sourced from the National Provider Identifier (NPI) registry and CMS Open Payments records.

Payment Summary

Dr. Christine Edwards has received a total of $16,564.42 in pharmaceutical industry payments across 1 recorded transactions in the CMS Open Payments database. The average payment amount is $16,564.42 per transaction.

Payment Breakdown by Category

The following table shows how Dr. Christine Edwards's pharmaceutical payments break down by payment category. Understanding the mix of payment types provides important context about the nature of the doctor-pharma relationship.

Payment CategoryAmountDescription
Consulting Fees$16,564.42Advisory board participation, clinical consulting, and expert opinion services

The largest payment category for Dr. Christine Edwards is Consulting Fees, accounting for 100% ($16,564.42) of total pharmaceutical payments received. This suggests active involvement in pharmaceutical company advisory and educational programs.

Pharmaceutical Company Relationships

The following pharmaceutical and medical device companies have made payments to Dr. Christine Edwards. Click on any company name to view their full physician payment profile and spending patterns.

CompanyTotal PaidTransactions
Johnson & Johnson$16,564.421

Dr. Christine Edwards has a financial relationship with Johnson & Johnson, receiving $16,564.42 in total. Having a single pharmaceutical company relationship means all payments come from one source, which may indicate a focused consulting or research relationship.

Drugs and Medical Devices Referenced in Payments

The following drugs and medical devices have been referenced in pharmaceutical payments to Dr. Christine Edwards. These references indicate that the payment was related to the marketing, consulting, or clinical use of these products.

The presence of a drug or device in a payment record means the pharmaceutical company associated the payment with that product. This is common for consulting fees related to a specific medication, speaking engagements about a product, or research involving a particular drug or device.

AI Transparency Analysis

The following analysis was generated by artificial intelligence based on Dr. Christine Edwards's payment history, specialty peer comparisons, and payment pattern analysis. This analysis is not medical or legal advice.

Christine Edwards has received $16.6K across 1 pharmaceutical payments as a Dermatology physician in Los Angeles, CA. Top paying companies include Johnson & Johnson ($16.6K). Dr. Edwards received a single, substantial payment of $16,564 in 2024. This payment was exclusively for consulting services. The entire amount originated from one company, Johnson & Johnson, indicating a high degree of concentration.

Patient Guidance: Questions to Ask Your Doctor

If Dr. Christine Edwards is your physician, here is practical guidance on how to understand and discuss pharmaceutical industry relationships:

Consumers should be aware that while payments can indicate collaboration and research, they do not necessarily influence a doctor's treatment decisions. It's always best to discuss any concerns about potential conflicts of interest with your physician. Always feel free to ask your doctor directly about their pharmaceutical relationships.

Peer Comparison: How Dr. Christine Edwards Compares to Other Dermatology Physicians

As a dermatologist, Dr. Edwards' single payment for consulting is within the expected range for specialists engaging with pharmaceutical companies, though the amount is notable.

Recent Payment Records

The following table shows the most recent pharmaceutical industry payments recorded for Dr. Christine Edwards in the CMS Open Payments database. Click on any payment to view the full report.

CompanyAmountTypeDrug/DeviceDateConflict Level
Johnson & Johnson$16,564.42consultingWegovy2024-05-14Not Assessed

Frequently Asked Questions About Dr. Christine Edwards's Pharma Payments

Below are common questions patients ask about physician pharmaceutical payment data.

How much pharma money has Christine Edwards received?

Christine Edwards has received a total of $16.6K across 1 payments from pharmaceutical companies. This data is publicly reported under the CMS Open Payments (Sunshine Act) program.

Is Christine Edwards taking too much pharma money?

Christine Edwards has received $16.6K in pharmaceutical payments. Whether this is "too much" depends on the physician's specialty (Dermatology), the types of payments, and how they compare to peers. The largest payment category is consulting ($16.6K). Payment does not imply wrongdoing, but patients should be aware and can ask their doctor directly.

What pharma companies pay Christine Edwards?

The top pharmaceutical companies paying Christine Edwards are: Johnson & Johnson ($16.6K). These payments cover various categories including consulting, meals, speaking fees, and research grants.

What kinds of payments does Christine Edwards receive?

Christine Edwards's payments by type: consulting: $16.6K. Consulting fees suggest active advisory roles with pharmaceutical companies.

Should I switch doctors because of pharma payments?

Pharma payments alone are not typically reason to switch doctors. Many payments are routine (like meals at educational events) and do not indicate compromised care. Focus on: (1) whether your doctor explains treatment options clearly, (2) whether generic alternatives are discussed, (3) the overall pattern of payments, not individual transactions. If you have concerns, ask your doctor directly.

How do Christine Edwards's payments compare to other Dermatology doctors?

To compare, look at the total amount ($16.6K), number of payments (1), and the types of payments received. Dermatology physicians may receive different payment amounts depending on subspecialty, geographic location, and academic affiliation. Use CMS Open Payments data to compare across the specialty.

How can I verify Christine Edwards's payment data?

You can verify this data directly through the CMS Open Payments database at openpaymentsdata.cms.gov. Search by physician name or NPI number (1279557193). All data is reported by pharmaceutical companies and verified by CMS. DoctorPharmaData aggregates this public data for easier access.

Do pharma payments affect prescribing quality?

Research published in JAMA Internal Medicine and other peer-reviewed journals shows a statistical association between pharmaceutical payments and prescribing patterns. However, correlation does not equal causation. Many physician-industry interactions are legitimate (research, education, advisory boards). The Sunshine Act was created to promote transparency so patients can make informed decisions.

What stands out about Christine Edwards's pharma payment profile?

The doctor's payment profile is extremely concentrated, with 100% of the total amount coming from a single company and for a single service type. Christine Edwards has received $16.6K in total pharma payments.

How does Christine Edwards compare to peers in Dermatology?

As a dermatologist, Dr. Edwards' single payment for consulting is within the expected range for specialists engaging with pharmaceutical companies, though the amount is notable.

Are Christine Edwards's pharma relationships typical for Dermatology?

The payment is linked to a specific drug, Wegovy, suggesting a potential focus or advisory role related to this medication.

What should patients of Christine Edwards know about these payments?

Consumers should be aware that while payments can indicate collaboration and research, they do not necessarily influence a doctor's treatment decisions. It's always best to discuss any concerns about potential conflicts of interest with your physician.

What patterns are visible in Christine Edwards's payment history?

With only one payment recorded, it's difficult to establish a trend or broader pattern of engagement with the pharmaceutical industry.

Understanding This Doctor Payment Report

This transparency report for Dr. Christine Edwards is based on data from the CMS Open Payments database, which is maintained by the Centers for Medicare and Medicaid Services under the Physician Payments Sunshine Act. Here are important things to understand:

About the Physician Payments Sunshine Act

The Physician Payments Sunshine Act, enacted as Section 6002 of the Affordable Care Act in 2010, requires pharmaceutical and medical device companies to report payments and other transfers of value to physicians and teaching hospitals to CMS. This law was designed to increase transparency in the financial relationships between the healthcare industry and medical providers.

Under this law, Dr. Christine Edwards's pharmaceutical payments are publicly disclosed. The types of reportable transactions include consulting fees, compensated speaking or educational activities, honoraria, gifts, entertainment, food and beverages, travel and lodging, education or conference attendance, research grants, charitable contributions, royalties or licenses, current or prospective ownership interests, and direct compensation for services other than consulting.

The Open Payments data for Dr. Christine Edwards and all other physicians can be accessed at the official CMS Open Payments website.

Related Resources

Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice. Consult your healthcare provider about any concerns.